Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases

Ahmed I. Anwar, Abdul-rahman A. Hegazi, Hamsa Priya Bhuchakra, Joshua R. Nelson, Ty L. Birdsong, Cy J. Fontenot, Majed Zeibo, Moiz M. Fazal-ur-Rehman, Harrison P. Bieber, Claudia J. Spring, Joshua L. Smith, Ibraheem A. Hachem, Taranjit Singh, M. Farris Sawaya, Kevin S. Murnane, Alan D. Kaye · 2026

Read Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases by Ahmed I. Anwar, Abdul-rahman A. Hegazi, Hamsa Priya Bhuchakra, Joshua R. Nelson, Ty L. Birdsong, Cy J. Fontenot, Majed Zeibo, Moiz M. Fazal-ur-Rehman, Harrison P. Bieber, Claudia J. Spring, Joshua L. Smith, Ibraheem A. Hachem, Taranjit Singh, M. Farris Sawaya, Kevin S. Murnane, Alan D. Kaye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13516327.txt.

Description

Ahmed I Anwar leads a sixteen-author review of pridopidine, a candidate drug for neurodegenerative disease, published in 2026. Huntington's disease and ALS now get treatments that ease symptoms without slowing the underlying decay. Pridopidine crosses into the brain and switches on the sigma-1 receptor, a helper protein sitting where the cell's internal store meets its power plants. That switch steadies calcium signals, supports mitochondria, and raises anti-death activity inside neurons.

The review gathers the mechanism evidence and the clinical record so far. Dopamine pathways, which swing too high or too low across these diseases, form part of the picture, yet the drug barely touches the classic dopamine receptor. Available evidence suggests better motor outcomes and slower decline in Huntington's disease and ALS. Anwar's team presents sigma-1 activation as a plausible disease-modifying strategy, while the proof base continues to build.

Catalog record

CREATORAhmed I. Anwar, Abdul-rahman A. Hegazi, Hamsa Priya Bhuchakra, Joshua R. Nelson, Ty L. Birdsong, Cy J. Fontenot, Majed Zeibo, Moiz M. Fazal-ur-Rehman, Harrison P. Bieber, Claudia J. Spring, Joshua L. Smith, Ibraheem A. Hachem, Taranjit Singh, M. Farris Sawaya, Kevin S. Murnane, Alan D. Kaye
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE72 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13516327

Browse the full library · About the Tower of Babel